Dr. Sanket P. Borgaonkar, MD

Dr. Borgaonkar practices at Mann Cataract Surgery Center-Houston in Houston, Texas.

Dr. Borgaonkar's NPI, 1720408032, was assigned on April 25, 2014. Dr. Borgaonkar graduated from Texas A&M College of Medicine - Bryan in 2014. Dr. Borgaonkar holds Texas license R1503.

Dr. Borgaonkar's primary practice is Mann Cataract Surgery Center-Houston, at 5115 Fannin St, Ste 1010, Houston, TX 77004. The practice phone is (713) 580-2568.

Dr. Borgaonkar's primary practice is Mann Cataract Surgery Center-Houston in Houston, Texas. Dr. Borgaonkar is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is Houston Cardiovascular Associates. Dmand AI also links Dr. Borgaonkar to 2 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borgaonkar practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Borgaonkar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Borgaonkar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Borgaonkar is licensed in Texas.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic embolism thrombosis, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Borgaonkar treats.

CMS data shows 4,363 Medicare services from Dr. Borgaonkar across 35 procedure codes in 2024, for 600 Medicare patients. Medicare paid $690,164 for them.

CMS counts 600 Medicare patients who saw Dr. Borgaonkar in 2024. The largest group is 75 to 84, with 236 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Borgaonkar's median patient age at 71, with 47% women.

In 2024, Dr. Borgaonkar wrote 1,679 Medicare Part D claims for 242 patients. 81% of them were for generic drugs. CMS names the drug for 1,483 of them, across 30 drugs with 11 or more claims each, at $239,989 in total drug cost. In 2023, CMS named 1,168 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Borgaonkar for performance year 2024, reported as part of a group. Dr. Borgaonkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Borgaonkar as offering telehealth. CMS counts 50 procedures of coronary angioplasty and stenting by Dr. Borgaonkar, more than 84% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Borgaonkar, published from 2019 to 2021. 2019 was the busiest year, with 2. The most frequent topics are COVID-19, Diagnosis, Differential and Electrocardiography. Dr. Borgaonkar has published most often in Tex Heart Inst J. Dr. Borgaonkar's most frequent co-authors are Yochai Birnbaum, MD, Daniel Addison, MD and Mahboob Alam, MD.

CMS Open Payments shows 771 general payments to Dr. Borgaonkar from 41 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 85% of the total. Abbott Laboratories paid the most, $21,558.

Dr. Borgaonkar graduated from Texas A&M College of Medicine - Bryan in 2014.

Dr. Borgaonkar is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.